![](/img/cover-not-exists.png)
The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Decreases Bone Formation and Bone Mineral Density in Healthy Postmenopausal Women: A Randomized, Controlled Trial
Grey, Andrew, Bolland, Mark, Gamble, Greg, Wattie, Diana, Horne, Anne, Davidson, James, Reid, Ian R.Volume:
92
Language:
english
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI:
10.1210/jc.2006-2646
Date:
April, 2007
File:
PDF, 179 KB
english, 2007